Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis
NCT03624127
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
666
Enrollment
INDUSTRY
Sponsor class
Conditions
Psoriasis
Interventions
DRUG:
BMS-986165
OTHER:
Placebo
DRUG:
Apremilast
Sponsor
Bristol-Myers Squibb